AbstractGlycoprotein B (gB, gpUL55) is a major antigen for the induction of neutralizing antibodies against human cytomegalovirus, making it an attractive antigen for active and passive immunoprophylaxis. The immunodominant region on gB is the antigenic domain 1 (AD-1), a complex structure which requires a minimal linear amino acid sequence of more than 75 amino acids (aa 552–635) for antibody binding. We have analyzed the fine specificity of neutralizing and nonneutralizing AD-1-binding monoclonal antibodies. Point mutations were introduced into AD-1 and mutants were expressed as bacterial fusion proteins. The antigens were analyzed in immunoblots using a panel of 13 human and murine monoclonal antibodies. Complete loss of binding of all a...
Glycoprotein B (gB) of human cytomegalovirus (HCMV) is the dominating protein in the envelope of thi...
The use of neutralizing antibodies to identify the most effective antigen has been proposed as a st...
Vaccination against human cytomegalovirus (CMV) infection remains high priority. A recombinant form ...
AbstractGlycoprotein B (gB, gpUL55) is a major antigen for the induction of neutralizing antibodies ...
Glycoprotein B (gB, gpUL55) is a major antigen for the induction of neutralizing antibodies against ...
Glycoprotein B (gB, gpUL55) is a major antigen for the induction of neutralizing antibodies against ...
Glycoprotein B (gB, gpUL55) is the major antigen for the induction of neutralizing antibodies agains...
Glycoprotein B (gB, gpUL55) is the major antigen for the induction of neutralizing antibodies agains...
AbstractSite I of antigenic domain 2 (AD-2) on human cytomegalovirus glycoprotein B (gB) is poorly i...
AbstractSite I of antigenic domain 2 (AD-2) on human cytomegalovirus glycoprotein B (gB) is poorly i...
Glycoprotein B (gB, gpUL55) is the major antigen recognized by the neutralizing humoral immune respo...
The capability of the antibody (Ab) repertoire to mount a response to appropriate epitopes on infect...
Antibodies provide some protection against cytomegalovirus-mediated disease. All aspects of antibody...
Human cytomegalovirus (HCMV), a herpesvirus, is a ubiquitously distributed pathogen that causes seve...
Site I of antigenic domain 2 (AD-2) on human cytomegalovirus glycoprotein B (gB) is poorly immunogen...
Glycoprotein B (gB) of human cytomegalovirus (HCMV) is the dominating protein in the envelope of thi...
The use of neutralizing antibodies to identify the most effective antigen has been proposed as a st...
Vaccination against human cytomegalovirus (CMV) infection remains high priority. A recombinant form ...
AbstractGlycoprotein B (gB, gpUL55) is a major antigen for the induction of neutralizing antibodies ...
Glycoprotein B (gB, gpUL55) is a major antigen for the induction of neutralizing antibodies against ...
Glycoprotein B (gB, gpUL55) is a major antigen for the induction of neutralizing antibodies against ...
Glycoprotein B (gB, gpUL55) is the major antigen for the induction of neutralizing antibodies agains...
Glycoprotein B (gB, gpUL55) is the major antigen for the induction of neutralizing antibodies agains...
AbstractSite I of antigenic domain 2 (AD-2) on human cytomegalovirus glycoprotein B (gB) is poorly i...
AbstractSite I of antigenic domain 2 (AD-2) on human cytomegalovirus glycoprotein B (gB) is poorly i...
Glycoprotein B (gB, gpUL55) is the major antigen recognized by the neutralizing humoral immune respo...
The capability of the antibody (Ab) repertoire to mount a response to appropriate epitopes on infect...
Antibodies provide some protection against cytomegalovirus-mediated disease. All aspects of antibody...
Human cytomegalovirus (HCMV), a herpesvirus, is a ubiquitously distributed pathogen that causes seve...
Site I of antigenic domain 2 (AD-2) on human cytomegalovirus glycoprotein B (gB) is poorly immunogen...
Glycoprotein B (gB) of human cytomegalovirus (HCMV) is the dominating protein in the envelope of thi...
The use of neutralizing antibodies to identify the most effective antigen has been proposed as a st...
Vaccination against human cytomegalovirus (CMV) infection remains high priority. A recombinant form ...